Post-earnings recap
Reported
Wed, Aug 13, 2025
EPS actual
$-1.03
EPS est.
$-0.95
EPS surprise
-8.08%
1-day move
+1.17%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Kodiak Sciences reported a loss that was slightly worse than expected, which did not seem to deter investor confidence, as the stock rose by 1.17%. The management's focus on research and development and future trials suggests they are looking to build on their pipeline. Investors may be encouraged by the long-term strategy despite the current EPS miss.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.03 | N/A | -8.08% |
| Revenue | N/A | N/A | N/A |
Management expressed cautious optimism about future projects. They are focused on advancing their pipeline and remain committed to long-term goals.
Management highlighted ongoing efforts in research and development.
They emphasized the importance of upcoming trials for future growth.
The team remains focused on long-term strategic goals despite current challenges.